000650 仁和药业
已收盘 10-30 15:00:00
资讯
新帖
简况
仁和药业：公司第二增长曲线是除传统医药或大健康板块外创新业务
证券之星 · 10-30 15:42
仁和药业：公司第二增长曲线是除传统医药或大健康板块外创新业务
股市必读：仁和药业（000650）10月29日董秘有最新回复
证券之星 · 10-30 06:17
股市必读：仁和药业（000650）10月29日董秘有最新回复
仁和药业：上述对应持股比例分别为1.5365%、0.76%、16.65%和20%
证券之星 · 10-29
仁和药业：上述对应持股比例分别为1.5365%、0.76%、16.65%和20%
仁和药业（000650）2026年三季报简析：净利润同比下降1.84%
证券之星 · 10-28
仁和药业（000650）2026年三季报简析：净利润同比下降1.84%
仁和药业：收购江西中进药业有限公司少数股东股权
证券之星 · 10-27
仁和药业：收购江西中进药业有限公司少数股东股权
仁和药业（000650）披露2026年三季度报告，10月27日股价下跌2.32%
证券之星 · 10-27
仁和药业（000650）披露2026年三季度报告，10月27日股价下跌2.32%
仁和药业(000650)10月20日股东户数8.9万户，较上期增加0.34%
证券之星 · 10-27
仁和药业(000650)10月20日股东户数8.9万户，较上期增加0.34%
股市必读：仁和药业（000650）10月23日董秘有最新回复
证券之星 · 10-26
股市必读：仁和药业（000650）10月23日董秘有最新回复
仁和药业：公司眼部产品主要还是药品
证券之星 · 10-23
仁和药业：公司眼部产品主要还是药品
仁和药业：公司第二增长曲线是除传统医药或大健康板块外创新业务
证券之星 · 10-23
仁和药业：公司第二增长曲线是除传统医药或大健康板块外创新业务
仁和药业(000650)10月20日股东户数8.9万户，较上期增加0.34%
证券之星 · 10-21
仁和药业(000650)10月20日股东户数8.9万户，较上期增加0.34%
仁和药业：报道涉及产品非公司生产和销售的产品
证券之星 · 10-21
仁和药业：报道涉及产品非公司生产和销售的产品
仁和药业：截至2026年10月20日，大约8.90万户左右
证券之星 · 10-21
仁和药业：截至2026年10月20日，大约8.90万户左右
股市必读：仁和药业（000650）10月16日董秘有最新回复
证券之星 · 10-19
股市必读：仁和药业（000650）10月16日董秘有最新回复
仁和药业：公司第二期员工持股计划的实施严格依据公司第二期员工持股计划（草案）（修订稿）方案执行
证券之星 · 10-16
仁和药业：公司第二期员工持股计划的实施严格依据公司第二期员工持股计划（草案）（修订稿）方案执行
股市必读：仁和药业新发布《公司关于第二期员工持股计划股票出售完毕的公告》
证券之星 · 10-15
股市必读：仁和药业新发布《公司关于第二期员工持股计划股票出售完毕的公告》
股市必读：仁和药业新发布《公司关于第二期员工持股计划股票出售完毕的公告》
证券之星 · 10-14
股市必读：仁和药业新发布《公司关于第二期员工持股计划股票出售完毕的公告》
股市必读：仁和药业（000650）10月12日董秘有最新回复
证券之星 · 10-13
股市必读：仁和药业（000650）10月12日董秘有最新回复
仁和药业：截至2026年10月9日，大约8.87万户左右
证券之星 · 10-12
仁和药业：截至2026年10月9日，大约8.87万户左右
股市必读：仁和药业（000650）9月24日董秘有最新回复
证券之星 · 09-28
股市必读：仁和药业（000650）9月24日董秘有最新回复
加载更多
公司概况
公司名称：
仁和药业股份有限公司
所属行业：
医药制造业
上市日期：
1996-12-10
主营业务：
仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是药品、健康相关产品。
发行价格：
6.26
{"stockData":{"symbol":"000650","market":"SZ","secType":"STK","nameCN":"仁和药业","latestPrice":5.03,"timestamp":1793343834000,"preClose":4.98,"halted":0,"volume":18984000,"delay":0,"changeRate":0.01,"floatShares":1331000000,"shares":1400000000,"eps":0.276,"marketStatus":"已收盘","change":0.05,"latestTime":"10-30 15:00:00","open":4.96,"high":5.09,"low":4.93,"amount":95514900,"amplitude":0.0321,"askPrice":5.04,"askSize":369,"bidPrice":5.03,"bidSize":901,"shortable":0,"etf":0,"ttmEps":0.276,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.98,"symbolType":"stock","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":5.48,"lowLimit":4.48,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1399938234,"isCdr":false,"pbRate":1.09,"roa":"--","peRate":18.224638,"roe":"5.79%","epsLYR":0.28,"committee":-0.145706,"marketValue":7042000000,"turnoverRate":0.0143,"status":0,"floatMarketCap":6697000000},"requestUrl":"/m/hq/s/000650","defaultTab":"news","newsList":[{"id":"2679267821","title":"仁和药业：公司第二增长曲线是除传统医药或大健康板块外创新业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2679267821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679267821?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:42","pubTimestamp":1793346131,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！贵公司在互动平台回复的第二增长曲线是什么？是否是对外股权投资？仁和药业回复：尊敬的投资者，您好！公司第二增长曲线是除传统医药或大健康板块外创新业务。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000034420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239","BK1515","09939","159938","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679230311","title":"股市必读：仁和药业（000650）10月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2679230311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679230311?lang=zh_cn&edition=full","pubTime":"2026-10-30 06:17","pubTimestamp":1793312261,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，仁和药业报收于4.98元，下跌0.8%，换手率1.12%，成交量14.9万手，成交额7432.75万元。董秘最新回复投资者： 董秘您好！截止目前贵公司对北京洛必德、睿晶半导体、南京招银现代、杭州飞镖夏焱的持股比例各是多少？上述对应持股比例分别为1.5365%、0.76%、16.65%和20%，年度报告里面有相关内容。当日关注点交易信息汇总：10月29日主力资金净流出229.88万元，占总成交额3.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000010109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679579441","title":"仁和药业：上述对应持股比例分别为1.5365%、0.76%、16.65%和20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679579441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679579441?lang=zh_cn&edition=full","pubTime":"2026-10-29 09:15","pubTimestamp":1793236511,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！截止目前贵公司对北京洛必德、睿晶半导体、南京招银现代、杭州飞镖夏焱的持股比例各是多少？对外投资收益占贵公司总收益的比例是多少？仁和药业回复：尊敬的投资者，您好！上述对应持股比例分别为1.5365%、0.76%、16.65%和20%，年度报告里面有相关内容。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900016051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678460316","title":"仁和药业（000650）2026年三季报简析：净利润同比下降1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678460316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678460316?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:20","pubTimestamp":1793190028,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期仁和药业发布2026年三季报。根据财报显示，仁和药业净利润同比下降1.84%。截至本报告期末，公司营业总收入27.92亿元，同比下降1.48%，归母净利润3.72亿元，同比下降1.84%。按单季度数据看，第三季度营业总收入7.01亿元，同比下降18.37%，第三季度归母净利润8022.22万元，同比下降9.57%。财报体检工具显示：建议关注公司应收账款状况本文数据来源于仁和药业2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800047081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678170579","title":"仁和药业：收购江西中进药业有限公司少数股东股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2678170579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678170579?lang=zh_cn&edition=full","pubTime":"2026-10-27 20:52","pubTimestamp":1793105544,"startTime":"0","endTime":"0","summary":"本次股权收购标的为江西中进药业有限公司，该公司是已纳入公司合并报表范围的控股孙公司，收购不会导致合并报表范围发生变化。本次收购少数股东股权有利于进一步加强整体经营管理，提升其经营决策效率，符合公司整体发展战略规划。收购所需资金为公司自有或自筹资金，不会对公司财务及经营状况产生重大不利影响，不会损害公司及股东特别是中小股东的权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700042108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678007179","title":"仁和药业（000650）披露2026年三季度报告，10月27日股价下跌2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678007179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678007179?lang=zh_cn&edition=full","pubTime":"2026-10-27 19:17","pubTimestamp":1793099848,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘，仁和药业报收于5.05元，较前一交易日下跌2.32%，最新总市值为70.7亿元。仁和药业于2026年10月27日披露《2026年三季度报告》。报告显示，本报告期营业收入700,710,999.27元，同比下降18.37%；归属于上市公司股东的净利润80,222,169.09元，同比下降9.57%。年初至报告期末营业收入2,791,652,026.30元，同比下降1.48%；归属于上市公司股东的净利润372,171,309.37元，同比下降1.84%。总资产7,770,304,822.80元，较上年度末增长0.45%；归属于上市公司股东的所有者权益6,380,058,723.62元，较上年度末增长1.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700037034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0239","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678173283","title":"仁和药业(000650)10月20日股东户数8.9万户，较上期增加0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678173283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678173283?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:37","pubTimestamp":1793097473,"startTime":"0","endTime":"0","summary":"证券之星消息，近日仁和药业披露，截至2026年10月20日公司股东户数为8.9万户，较10月9日增加300.0户，增幅为0.34%。在中药行业个股中，仁和药业股东户数高于行业平均水平，截至10月20日，中药行业平均股东户数为5.24万户。从股价来看，2026年10月9日至2026年10月20日，仁和药业区间跌幅为3.02%，在此期间股东户数增加300.0户，增幅为0.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700034609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678131651","title":"股市必读：仁和药业（000650）10月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2678131651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678131651?lang=zh_cn&edition=full","pubTime":"2026-10-26 06:11","pubTimestamp":1792966273,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，仁和药业报收于5.09元，上涨0.99%，换手率1.42%，成交量18.86万手，成交额9481.69万元。董秘最新回复投资者： 董秘您好！目前公司没有自研、自产和销售狭义生物制药产品。公司第二增长曲线是除传统医药或大健康板块外创新业务。在研的眼部药品还有富马酸依美斯汀滴眼液。当日关注点交易信息汇总：10月23日主力资金净流入229.54万元，占总成交额2.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677922778","title":"仁和药业：公司眼部产品主要还是药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2677922778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677922778?lang=zh_cn&edition=full","pubTime":"2026-10-23 20:52","pubTimestamp":1792759932,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业10月23日在投资者关系平台上答复投资者关心的问题。公司眼部产品主要还是药品，如复方门冬维甘滴眼液和萘敏维滴眼液，用于缓解眼睛疲劳、结膜充血以及眼睛发痒等症状。玻璃酸钠滴眼液，用于干眼症，缓解干眼症状。盐酸莫西沙星滴眼液临床用于敏感微生物引起的细菌性结膜炎的治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300042281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677452639","title":"仁和药业：公司第二增长曲线是除传统医药或大健康板块外创新业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2677452639","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677452639?lang=zh_cn&edition=full","pubTime":"2026-10-23 15:06","pubTimestamp":1792739181,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)10月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！贵公司的第二增长曲线是什么？仁和药业回复：尊敬的投资者，您好！公司第二增长曲线是除传统医药或大健康板块外创新业务。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300022682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0239","BK0188","BK1515","000650","159938","BK0097","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677622863","title":"仁和药业(000650)10月20日股东户数8.9万户，较上期增加0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677622863","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677622863?lang=zh_cn&edition=full","pubTime":"2026-10-21 17:29","pubTimestamp":1792574993,"startTime":"0","endTime":"0","summary":"证券之星消息，近日仁和药业披露，截至2026年10月20日公司股东户数为8.9万户，较10月9日增加300.0户，增幅为0.34%。在中药行业个股中，仁和药业股东户数高于行业平均水平，截至10月20日，中药行业平均股东户数为5.23万户。从股价来看，2026年10月9日至2026年10月20日，仁和药业区间跌幅为3.02%，在此期间股东户数增加300.0户，增幅为0.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100029999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677623262","title":"仁和药业：报道涉及产品非公司生产和销售的产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2677623262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677623262?lang=zh_cn&edition=full","pubTime":"2026-10-21 15:12","pubTimestamp":1792566726,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)10月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，这次央视财经报道的的问题是仁和集团还是仁和药业？给公司中长期和短期经营造成什么样的影响呢？仁和药业回复：尊敬的投资者，您好！公司证券部关注到此次媒体报道，报道涉及产品非公司生产和销售的产品。目前暂无影响，但公司证券部密切关注后续结果。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100020969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677064649","title":"仁和药业：截至2026年10月20日，大约8.90万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2677064649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677064649?lang=zh_cn&edition=full","pubTime":"2026-10-21 11:36","pubTimestamp":1792553782,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)10月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年10月20日A股股东人数是多少？谢谢仁和药业回复：尊敬的投资者，谢谢您的关注，截至2026年10月20日，大约8.90万户左右。具体数据，根据相关法规，请您先向公司证券部提交股东身份证明，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100016668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676578115","title":"股市必读：仁和药业（000650）10月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2676578115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676578115?lang=zh_cn&edition=full","pubTime":"2026-10-19 01:39","pubTimestamp":1792345148,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘，仁和药业报收于5.13元，下跌0.97%，换手率1.66%，成交量22.14万手，成交额1.15亿元。董秘最新回复投资者： 公司有利用AI技术，改良药效吗？当日关注点交易信息汇总：10月16日主力资金净流出1026.35万元，占总成交额8.91%。交易信息汇总：当日散户资金净流入1054.14万元，占总成交额9.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675456452","title":"仁和药业：公司第二期员工持股计划的实施严格依据公司第二期员工持股计划（草案）（修订稿）方案执行","url":"https://stock-news.laohu8.com/highlight/detail?id=2675456452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675456452?lang=zh_cn&edition=full","pubTime":"2026-10-16 15:48","pubTimestamp":1792136890,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)10月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司前些年回购股份用于股权激励，在激励条件达不到的情况下，为何在股价如此低迷的情况下出售，而不是注销以提升每股收益？仁和药业回复：尊敬的投资者，您好！公司第二期员工持股计划的实施严格依据公司第二期员工持股计划（草案）（修订稿）方案执行。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600023275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675255324","title":"股市必读：仁和药业新发布《公司关于第二期员工持股计划股票出售完毕的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675255324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675255324?lang=zh_cn&edition=full","pubTime":"2026-10-15 03:34","pubTimestamp":1792006450,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，仁和药业报收于5.22元，上涨0.0%，换手率0.93%，成交量12.38万手，成交额6475.13万元。公司公告汇总公司关于第二期员工持股计划股票出售完毕的公告仁和药业股份有限公司第二期员工持股计划所持有的1550万股公司股票已通过二级市场全部出售完毕，占公司总股本的1.1072%。因公司两年考核目标未达标，无法满足解锁条件，公司决定提前终止该员工持股计划，并已公告相关事项。本次出售严格遵守交易规则，未利用内幕信息交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500003672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675369308","title":"股市必读：仁和药业新发布《公司关于第二期员工持股计划股票出售完毕的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675369308","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675369308?lang=zh_cn&edition=full","pubTime":"2026-10-14 01:22","pubTimestamp":1791912130,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，仁和药业报收于5.22元，下跌0.95%，换手率1.38%，成交量18.37万手，成交额9574.55万元。公司公告汇总：仁和药业第二期员工持股计划所持1550万股股票已全部出售完毕，因两年考核目标未达标，该计划提前终止。后续将进行资产清算和分配工作。本次出售严格遵守交易规则，未利用内幕信息交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675804852","title":"股市必读：仁和药业（000650）10月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675804852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675804852?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:26","pubTimestamp":1791825975,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，仁和药业报收于5.27元，下跌0.38%，换手率1.12%，成交量14.9万手，成交额7881.91万元。董秘最新回复投资者： 尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年10月9日A股股东人数是多少？谢谢董秘： 尊敬的投资者，谢谢您的关注，截至2026年10月9日，大约8.87万户左右。当日关注点交易信息汇总：10月12日主力资金净流出817.88万元，占总成交额10.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674982404","title":"仁和药业：截至2026年10月9日，大约8.87万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2674982404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674982404?lang=zh_cn&edition=full","pubTime":"2026-10-12 15:06","pubTimestamp":1791788783,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)10月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年10月9日A股股东人数是多少？谢谢仁和药业回复：尊敬的投资者，谢谢您的关注，截至2026年10月9日，大约8.87万户左右。具体数据，根据相关法规，请您先向公司证券部提交股东身份证明，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200014332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000650","BK0097","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670094494","title":"股市必读：仁和药业（000650）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670094494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670094494?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:04","pubTimestamp":1790532255,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，仁和药业报收于5.13元，下跌1.16%，换手率0.99%，成交量13.24万手，成交额6824.72万元。董秘最新回复投资者： 公司是否有种植中草药的产业，节约成本，从源头控制质量董秘： 尊敬的投资者，谢谢您对公司的关注，公司目前没有种植中药材的业务，但有中药材收储基地。目前没有，未来会根据公司发展情况进行研判。当日关注点交易信息汇总：9月24日主力资金净流出713.44万元，占总成交额10.45%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793568170616,"stockEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0401},{"period":"3month","weight":-0.0737},{"period":"6month","weight":-0.0919},{"period":"1year","weight":-0.1543},{"period":"ytd","weight":-0.0855}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"仁和药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"89000人(较上一季度增加0.34%)","perCapita":"14959股","listingDate":"1996-12-10","address":"江西省宜春市樟树市葛玄路6号","registeredCapital":"139993万元","survey":" 仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是药品、健康相关产品。","listedPrice":6.26},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仁和药业,000650,仁和药业股票,仁和药业股票老虎,仁和药业股票老虎国际,仁和药业行情,仁和药业股票行情,仁和药业股价,仁和药业股市,仁和药业股票价格,仁和药业股票交易,仁和药业股票购买,仁和药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}